CasirivimabImdevimabSARS-CoV-2:

Meagan P O'Brien1, Eduardo Forleo-Neto1, Neena Sarkar1

  • 1Regeneron Pharmaceuticals Inc, Tarrytown, New York.

JAMA
|January 14, 2022
PubMed
概括

皮下用卡西里维玛和伊姆迪维玛治疗显著降低了无症状个体的COVID-19进展. 这种早期干预也减少了症状持续时间和病毒载量.